2024
High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children
Watkins T, Green A, Amat J, Cheemarla N, Hänsel K, Lozano R, Dudgeon S, Germain G, Landry M, Schulz W, Foxman E. High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children. Journal Of Experimental Medicine 2024, 221: e20230911. PMID: 38949638, PMCID: PMC11215523, DOI: 10.1084/jem.20230911.Peer-Reviewed Original ResearchConceptsBacterial pathobiontsRespiratory virusesBurden of virusesSARS-CoV-2Innate immune activationSARS-CoV-2 viral loadDynamic host-pathogen interactionsInnate immune responseViral coinfectionCytokine profileViral loadNasal virusImmune activationProinflammatory responseIL-1BNasopharyngeal samplesHost-pathogen interactionsImmune responseInterferon responsePathobiontsInnate immunityPaired samplesCXCL10Healthy 1-year-oldVirus
2023
Double-take: SARS-CoV-2 has evolved to evade human innate immunity, twice
Foxman E. Double-take: SARS-CoV-2 has evolved to evade human innate immunity, twice. Trends In Immunology 2023, 45: 1-3. PMID: 38143224, DOI: 10.1016/j.it.2023.12.001.Peer-Reviewed Original ResearchViral Interference During Influenza A–SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir
Cheemarla N, Watkins T, Mihaylova V, Foxman E. Viral Interference During Influenza A–SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir. The Journal Of Infectious Diseases 2023, 229: 1430-1434. PMID: 37722683, PMCID: PMC11095529, DOI: 10.1093/infdis/jiad402.Peer-Reviewed Original ResearchSARS-CoV-2 replicationSARS-CoV-2IAV replicationHuman airway epithelial culturesHuman airway epitheliumAirway epithelial culturesHost antiviral responseRobust interferon responseInfluenza infectionRespiratory virusesAirway epitheliumViral infectionAntiviral responseViral interferenceCoinfecting virusSimultaneous infectionHost cell defenseInterferon responseCoinfectionInfectionEpithelial culturesOseltamivirInfluenzaVirusCell defenseRespiratory viruses: New frontiers—a Keystone Symposia report
Cable J, Sun J, Cheon I, Vaughan A, Castro I, Stein S, López C, Gostic K, Openshaw P, Ellebedy A, Wack A, Hutchinson E, Thomas M, Langlois R, Lingwood D, Baker S, Folkins M, Foxman E, Ward A, Schwemmle M, Russell A, Chiu C, Ganti K, Subbarao K, Sheahan T, Penaloza‐MacMaster P, Eddens T. Respiratory viruses: New frontiers—a Keystone Symposia report. Annals Of The New York Academy Of Sciences 2023, 1522: 60-73. PMID: 36722473, PMCID: PMC10580159, DOI: 10.1111/nyas.14958.Peer-Reviewed Original ResearchConceptsRespiratory virusesSARS-CoV-2Specific viral strainsMechanisms of diseaseAcute infectionChronic diseasesCommon causeEffective treatmentNovel treatmentsVirus-host interactionsPrevention strategiesTherapy efficacyViral strainsVulnerable populationsPrevention approachesVirusDiseaseSymposium reportTreatmentViral biologyMorbidityPopulationInfectionMortalityInfluenza